Jason B. Thompson

Safety and immunogenicity of a Zika purified inactivated virus vaccine given via standard, accelerated, or shortened schedules: a single-centre, double-blind, sequential-group, randomised, placebo-controlled, phase 1 trial.

Stephen J. Thomas, N. Michael, D. Barouch, 2020, The Lancet. Infectious diseases.

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials

Alison E Kosel, K. Meyer, M. Robb, 2017, The Lancet.

Who's left? Symptoms of schizophrenia that predict clinical trial dropout

M. Berk, A. Bush, D. Copolov, 2011, Human psychopharmacology.

Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate given via standard versus accelerated vaccination schedules: a phase 1, single-center, double-blind, sequential-group, randomized, placebo-controlled clinical trial

Joseph, N. Michael, D. Barouch, 2020 .

Autologous Hematopoietic Stem Cell Transplantation (AHCT) in Patients with Chemotherapy-Sensitive, Relapsed/Refractory (CSRR) Human Immunodeficiency Virus (HIV)-Associated Lymphoma (HAL): Results from the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0803)/AIDS Malignancy Consortium (

U. Popat, S. Devine, R. Ambinder, 2014 .

Autologous hematopoietic cell transplantation for HIV-related lymphoma: results of the BMT CTN 0803/AMC 071 trial.

A. Krishnan, G. Lozanski, M. Horowitz, 2016, Blood.

No Survival Advantage After Double Umbilical Cord Blood (UCB) Compared to Single UCB Transplant in Children with Hematological Malignancy: Results of the Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0501) Randomized Trial

J. Wagner, J. Kurtzberg, D. Wall, 2012 .

Medication dosing errors for patients with renal insufficiency in ambulatory care.

David Baker, Jason B. Thompson, D. Dunham, 2005, Joint Commission journal on quality and patient safety.